Dadlani started as chief executive of Optum Insight last week, the executive announced in a LinkedIn post saying he’s “honored and privileged” to step into the role. Dadlani first joined UnitedHealth ...

Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...